Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination

Published:2018-01 Issue: Volume:97 Page:115-119
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhao Qian,Guan Jiawei,Qin Yuanhua,Ren Peng,Zhang Zhiwei,Lv Jian,Sun Shijie,Zhang Cuili,Mao Weifeng

Funder

Chinese National Scientific Foundation to Weifeng Mao

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference30 articles.

1. Curcumin: from ancient medicine to current clinical trials;Hatcher;Cell. Mol. Life Sci.,2008

2. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1;Chen;Oncogene,2006

3. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1;Chen;Cancer Res.,2008

4. The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway;Jia;Cancer Cell Int.,2014

5. Curcumin: the spicy modulator of breast carcinogenesis;Banik;J. Exp. Clin. Cancer Res.: CR,2017

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytocompounds and Nanoformulations for Anticancer Therapy: A Review;Molecules;2024-08-09

2. Targeting the DNA damage response (DDR) of cancer cells with natural compounds derived from Panax ginseng and other plants;Journal of Ginseng Research;2024-04

3. Natural products reverse cancer multidrug resistance;Frontiers in Pharmacology;2024-03-08

4. Curcumin in treatment of hematological cancers: Promises and challenges;Journal of Traditional and Complementary Medicine;2024-03

5. Role of natural products in tumor therapy from basic research and clinical perspectives;Acta Materia Medica;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3